Keeping Track: Gazyva, Afinitor Get New Indications; PTC's Translarna Gets Refuse To File
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: Clarus, Agile and Sunovion Look To Bounce Back From CRLs; FDA To Review Rituximab Biosimilar
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: US FDA Expands Indications For Roche Tecentriq, Lucentis, Approves Second Infliximab Biosimilar
The latest drug development news and highlights from our FDA Performance Tracker.
Keeping Track: Oncology Approvals And Responses To Complete Response Letters
The latest drug development news and highlights from our FDA Performance Tracker.